about
Equine CTNNB1 and PECAM1 nucleotide structure and expression analyses in an experimental model of normal and pathological wound repair.Equine ANXA2 and MMP1 expression analyses in an experimental model of normal and pathological wound repair.Different media and supplements modulate the clonogenic and expansion properties of rabbit bone marrow mesenchymal stem cells.Laminin receptor 1 is differentially expressed in thoracic and limb wounds in the horse.Equine thrombospondin II and secreted protein acidic and cysteine-rich in a model of normal and pathological wound repair.A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells.Efficacy of low-level laser therapy on hair regrowth in dogs with noninflammatory alopecia: a pilot study.Effect of 1,3-1,6 β-Glucan on Natural and Experimental Deformed Wing Virus Infection in Newly Emerged Honeybees (Apis mellifera ligustica)Morphometric Evaluation of Interrenal Gland and Kidney Macrophages Aggregates in Normal Healthy Rainbow Trout (Oncorhynchus mykiss) and after Bacterial Challenge with Yersinia ruckeriOB-cadherin cloning and expression in a model of wound repair in horses.In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity.Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery.Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.Preferential epithelial expression of type-1 cannabinoid receptor (CB1R) in the developing canine embryo.Effect of a hydrocolloid dressing on first intention healing surgical wounds in the dog: a pilot study.Spatial distribution of cannabinoid receptor 1 and fatty acid amide hydrolase in the cat ovary and oviduct.Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide hydrolase in the dog claustrum.Isolation and expansion of equine umbilical cord-derived matrix cells (EUCMCs).Equine lumican (LUM) cDNA sequence and spatio-temporal expression in an experimental model of normal and pathological wound healing.The catecholaminergic innervation of the claustrum of the pig.Osteopontin expression in healing wounds of horses and in human keloids.Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture model.Deslorelin for the treatment of hair cycle arrest in intact male dogs.Establishment of a 2-week canine skin organ culture model and its pharmacological modulation by epidermal growth factor and dexamethasone.An autologously generated platelet-rich plasma suturable membrane may enhance peripheral nerve regeneration after neurorraphy in an acute injury model of sciatic nerve neurotmesis.Tailored star poly (ε-caprolactone) wet-spun scaffolds for in vivo regeneration of long bone critical size defectsCannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitisImmunolocalisation of desmoglein-1 in equine muzzle skinImmunohistochemical analysis of the distribution of desmoglein 1 and 2 in the skin of dogs and catsNormal microscopic anatomy of equine body and limb skin: A morphological and immunohistochemical studyCannabinoid receptor types 1 and 2 and peroxisome proliferator-activated receptor-α: distribution in the skin of clinically healthy cats and cats with hypersensitivity dermatitisThe Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1Epithelial-to-mesenchymal transition and keratinocyte differentiation in equine experimental body and limb wounds healing by second intentionMorphological alterations of the reticular thalamic nucleus in Engrailed-2 knockout miceAging-associated perifollicular changes and calcium deposition in poodles
P50
Q30840661-1059D53A-F685-4BF6-8743-D87918B1A44DQ33330569-7D79A5C5-E23D-448C-9FAB-4B3266F9F5AAQ33360948-9DA8AED6-1CB1-4627-9060-9CCE6656DB0AQ33397148-6E79ED17-F177-4FCA-9201-4990484F6E0EQ33436134-E7B2A246-B35F-41AC-9F92-EAD5675B8717Q34533003-8B8EC86D-D81F-45DE-AB0B-BF7B9AC3E54CQ35256728-DA3A64F1-A0C9-4DD6-ABB2-F4ABA425E197Q36187471-76432C6B-1F32-46F0-8746-F48248D4F453Q37641483-ED832851-87FC-4441-84DF-DE87246DB5B8Q38357155-A696C703-17EB-4FFF-AB36-0F74081EB7ECQ39445496-D5136AA5-968D-4F55-B7C0-2674B5D73646Q39772092-188355C0-B4D6-4098-B63F-DAA7F183D8FDQ40887305-4A18CBA6-B422-4213-8C95-31C5A33C8194Q41953638-6648BC9B-19C0-4789-86AA-E89AE9CA0496Q43119533-C55BA27B-62DB-4314-B3DC-B0A52A2D46D4Q44526580-4014D536-E6D2-47A7-A355-D9155EAB5CC9Q46370442-A16F885A-A086-4701-AB79-233D90FFFA36Q46591325-B1F0853E-C7E0-4547-8A13-9DE4470615B3Q47245371-42EF7DE2-9899-4877-85A6-164FBBC95B9AQ47991204-3504A4EA-F5DC-4703-8004-53826E30AAF0Q48088844-23882914-6C6E-4D6A-AD3C-B693045282D6Q48263513-6E39453E-EF8B-4ADB-A251-68A210B00A1EQ48323713-EB1A7838-1E4D-4C05-A03C-7C2F0CE182D6Q51124782-9DA6A997-D8CC-4062-86D9-C0E9FDD50D30Q51383386-150EB025-0C81-4073-9B2A-3370B8E20546Q53549006-5C008957-8E2F-4A1F-9F70-D2CC97CB504EQ59584739-CFD68ADE-D297-41A7-949C-4516C286C8CCQ60690518-65CE45E9-0C4E-46CF-AC64-99A0C738AC6BQ80300818-F25D3B23-72C7-4EC4-BB52-8D81CBF51759Q81588986-B4D34421-690E-42E8-B05D-DB50BE9F3A8FQ88579933-3F96D441-62B9-4AA7-BC5A-D1741E43B99CQ89154384-2C6E7EDC-4756-4663-B6E7-0EFC6012D1B0Q89666889-36C86A6B-645D-4894-B5B5-7393A19340CFQ92062163-0CB03144-60AB-4FFC-B2F0-BF2559D91392Q92880368-29BAD5A0-8BF5-4FF2-AD27-D3F5380A7EC4Q93263710-8C6005BF-817B-42CC-9D62-3D047BC7FE8D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vincenzo Miragliotta
@ast
Vincenzo Miragliotta
@en
Vincenzo Miragliotta
@es
Vincenzo Miragliotta
@nl
Vincenzo Miragliotta
@sl
type
label
Vincenzo Miragliotta
@ast
Vincenzo Miragliotta
@en
Vincenzo Miragliotta
@es
Vincenzo Miragliotta
@nl
Vincenzo Miragliotta
@sl
prefLabel
Vincenzo Miragliotta
@ast
Vincenzo Miragliotta
@en
Vincenzo Miragliotta
@es
Vincenzo Miragliotta
@nl
Vincenzo Miragliotta
@sl
P1053
K-7361-2015
P106
P1153
23980837600
P21
P31
P3829
P496
0000-0001-7896-5695